Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11667649 Heteroaromatic macrocyclic ether chemotherapeutic agents

Patent 11667649 was granted and assigned to Nuvalent on June, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 7 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 25 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 25 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 7 Jun, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 7 Jun, 2023
Edits made to:
Infobox (+36 properties)
Article (+382 characters)
‌

 US Patent 11667649 Heteroaromatic macrocyclic ether chemotherapeutic agents

Article

Disclosed are heterocyclic heteroaromatic macrocyclic ether compounds, pharmaceutically acceptable salts of the compounds and pharmaceutical compositions thereof. Also disclosed are methods of treating or preventing cancer using the heterocyclic heteroaromatic macrocyclic ether compounds, pharmaceutically acceptable salts of the compounds, and pharmaceutical compositions thereof.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Nuvalent
Nuvalent
0
Current Assignee
Nuvalent
Nuvalent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116676490
Date of Patent
June 6, 2023
0
Patent Application Number
175241690
Date Filed
November 11, 2021
0
Patent Citations
‌
US Patent 7338973 Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
0
‌
US Patent 7514466 Purification of progesterone receptor modulators
0
‌
US Patent 7641703 Composition for the coloring of keratinous fibers comprising a halochromic compound and/or the dye corresponding to this compound, and method of use thereof
0
‌
US Patent 7915414 Blue-emitting organometallic complexes and their application
0
‌
US Patent 8012603 Polymer compound and polymer light-emitting device using the same
0
‌
US Patent 8129523 Coupling process for generating reactive boron-containing derivatives of N-substituted pyrrole-2-carbonitriles to produce biaryls
0
‌
US Patent 8178520 Macrocyclic compounds as antiviral agents
0
‌
US Patent 8580840 Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
0
‌
US Patent 8609712 Purification of progesterone receptor modulators
0
‌
US Patent 8680111 Macrocyclic derivatives for the treatment of diseases
0
‌
US Patent 9133168 Pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
0
‌
US Patent 9181265 Substituted 2,3-dihydro-1H-benzo[a]pyrano[2,3-c]phenazines as anti-angiogenic and anti-cancer agents
0
‌
US Patent 9318714 Material for organic electroluminescence device and organic electroluminescence device
0
‌
US Patent 9502667 Organic electroluminescence
0
‌
US Patent 9611274 Macrocycles as factor XIa inhibitors
0
‌
US Patent 9666809 Compound and organic light-emitting device including the same
0
‌
US Patent 9768393 Condensed-cyclic compound and organic light-emitting device including the same
0
‌
US Patent 9887372 Amine-based compound and organic light-emitting device including the same
0
‌
US Patent 9902742 Macrocycles as factor XIa inhibitors
0
‌
US Patent 9929358 Organic light-emitting devices
0
‌
US Patent 10147887 Compound and organic light-emitting device including the same
0
‌
US Patent 10189803 Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
0
‌
US Patent 10208068 Macrocycles as factor XIa inhibitors
0
‌
US Patent 10243153 Material for organic electroluminescence device and organic electroluminescence device
0
‌
US Patent 10335392 Cyclic compounds useful as modulators of TNF α
0
‌
US Patent 10593889 Compound and organic electroluminescence device
0
‌
US Patent 11008323 Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group II metabotropic glutamate receptors
0
Patent Primary Examiner
‌
Craig D Ricci
0

Find more entities like US Patent 11667649 Heteroaromatic macrocyclic ether chemotherapeutic agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo